CD19 Antibody (Immunohistochemistry)

The CD19 Antibody is a key marker for the identification of normal and malignant B-cells across various maturation stages.
It is one of the most reliable B-lineage markers, expressed in germinal centers, mantle zone cells, and scattered interfollicular B-cells in normal lymphoid tissue.

In pathology, CD19 positivity supports the diagnosis of B-cell lymphomas, including Follicular, Diffuse Large B-cell (DLBCL), and Burkitt’s Lymphoma.

🔬 Features and Benefits CD19 Antibody

Specific for B-cell lineage: Reliable identification of B-cell neoplasms

Distinct membrane staining: Brown coloration in B-cell membranes

Useful in lymphoma classification and differentiation

Compatible with standard IHC procedures

Stable for 18 months at 2–8 °C

💡 Diagnostic Applications

Detection of B-cell Lymphomas (DLBCL, Follicular, Burkitt’s)

Study of B-cell differentiation and maturation

Immunopathology and lymphoma subclassification research

🌐 Fardad Azma Rad Co.

Fardad Azma Rad Co., the exclusive representative of Talent Biomedical in Iran, provides high-quality immunohistochemistry antibodies, including CD19.
The company is dedicated to accuracy, reliability, and global diagnostic standards, serving pathology and molecular diagnostic laboratories across Iran

“Download Brochure”